Table 1b.
Solid tumor patient baseline characteristics.
| PROQOL (N = 100) | UC (N = 50) | Total (N = 150) | p value | |
|---|---|---|---|---|
| Age, years [median, range] | 63.5 (32–84) | 63 (39–81) | 63 (32–84) | 0.66 |
| Gender | 0.32 | |||
| Female | 81 (81.0%) | 37 (74.0%) | 118 (78.7%) | |
| Male | 19 (19.0%) | 13 (26.0%) | 32 (21.3%) | |
| Race | 0.48 | |||
| Native American | 1 (1.0%) | 0 (0.0%) | 1 (0.7%) | |
| White | 99 (99.0%) | 50 (100.0%) | 149 (99.3%) | |
| Distance travelled, miles [median, range] | 93 (3–1262) | 107 (3–3123) | 97.5 (3–3123) | 0.58 |
| Diagnosis | 0.28 | |||
| Head & Neck | 22 (22.0%) | 15 (30.0%) | 37 (24.7%) | |
| Gynecologic | 78 (78.0%) | 35 (70.0%) | 113 (75.3%) | |
| Disease status | 0.13 | |||
| Newly diagnosed | 49 (49.0%) | 18 (36.0%) | 67 (44.7%) | |
| Relapsed | 51 (51.0%) | 32 (64.0%) | 83 (55.3%) | |
PROQOL = patient-reported outcome quality of life tool; UC = usual care.